Jean-Charles Wirth and Danny Bar-Zohar are set to assume the life science and healthcare CEO roles respectively.

Gilead (GILD) stock won an upgrade from Deutsche Bank on HIV treatment boost, while Merck (MRK) stock received a downgrade on ...

The German pharmaceutical-and-chemicals company on Tuesday said it appointed Jean-Charles Wirth as new chief executive of life science. Wirth succeeds Matthias Heinzel, who decided to not renew his ...

Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Request To Download Free Sample of This Strategic Report@ Highlighted with 88 tables and 75 figures, this 196-page report ?Asia Pacific Active Pharmaceutical Ingredients (API) Market 2022-2032 by ...

Europe active pharmaceutical ingredients (API) market was valued at $ 49.4 billion in 2022 and will grow by 6.8% annually over 2022-2032, d riven by rising adoption of biologics in disease management, ...

Merck has not shied away from splashy takeovers in the past. In 2015, the company agreed to buy U.S. lab equipment supplier ...

Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated ...

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says ...

has shown consistent revenue growth given its diversified geographical presence and strong balance sheet. The research house said the company achieved a three-year compounded annual growth rate of ...

Astellas Pharma Inc., a global life sciences company committed to ... (ACP), a synthetic aptamer that inhibits the complement C5 protein, for the treatment of geographic atrophy (GA) secondary to ...